ストックスクリーナーアプリを入手
1.32
3.13%
0.04
アフターアワーズ：
1.34
0.02
+1.52%
Dare Bioscience Inc (DARE) 最新ニュース
Dare Bioscience Inc (DARE) Income Statement - TradingKey
Dare Bioscience Inc (DARE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Dare Bioscience Inc (DARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Dare Bioscience Inc (DARE) Cash Flow - TradingKey
Dare Bioscience Market Sentiment - Benzinga España
DARE|Dare Bioscience Inc|Price:1.280|Chg%:+0.020 - TradingKey
Dare Bioscience Inc (DARE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Daré Bioscience Releases New Investor Corporate Presentation - TipRanks
Dare Bioscience Inc (DARE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Daré Bioscience, Inc. (NASDAQ:DARE): Are Analysts Optimistic? - simplywall.st
Daré Bioscience launches virtual bus tour webin... - Pluang
Daré Bioscience Launches “Across the U.S.” Virtual Bus Tour Webinar Series for Investors - Quiver Quantitative
Daré Bioscience Launches Nationwide Virtual Bus Tour - GlobeNewswire
Daré Bioscience Files 8-K Notice of Delisting or Failure to Satisfy Nasdaq Listing Requirements – July 2026 - Minichart
Daré Bioscience Faces Nasdaq Listing Compliance Challenges - TipRanks
Dare Bioscience Received Notice of Delisting - TradingView
Daré Bioscience Advances DARE-HPV Trial, Raising New Questions for HPV Treatment Investors - TipRanks
Daré Bioscience at Virtual Investor Closing Bell: shift to sales By Investing.com - Investing.com Canada
DARE: Commercial launches and clinical milestones in women's health drive growth and value through 2027 - TradingView
Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025 - 富途牛牛
Daré Bioscience Updates Investors With New Presentation - TipRanks
[8-K] Dare Bioscience, Inc. Reports Material Event - Stock Titan
Dare Bioscience Company Profile & Introduction - Moomoo
Daré Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event - The Manila Times
Price to sales forward of Dare Bioscience, Inc. – NASDAQ:DARE - TradingView
DARE Technical Analysis & Stock Price Forecast - Intellectia AI
Daré Bioscience launches prescription-free vaginal probiotic capsule for microbiome support - Contemporary OB/GYN
Price to earnings forward of Dare Bioscience, Inc. – NASDAQ:DARE - TradingView
Dare Bioscience (DARE) director receives 23,696 RSUs in lieu of cash pay - Stock Titan
Dare Bioscience (DARE) director awarded 30,805 RSUs as board compensation - Stock Titan
Dare Bioscience (DARE) grants 38,862 RSUs to board director - Stock Titan
Dare Bioscience (DARE) director receives 26,540 RSUs in lieu of cash fees - Stock Titan
Director Jessica Grossman gets 26,066 RSUs at Dare Bioscience (NASDAQ: DARE) - Stock Titan
Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform - The Manila Times
Daré Bioscience Launches Flora Sync LF5 Vaginal Probiotic, Marks First Direct Consumer Product Revenue - Quiver Quantitative
Daré Bioscience’s vaginal probiotic is now for sale online - Stock Titan
Daré Bioscience, Inc.(NasdaqCM: DARE) added to Russell 3000E Growth Benchmark - marketscreener.com
Daré Bioscience, Inc.(NasdaqCM: DARE) added to Russell 3000E Index - marketscreener.com
Daré Bioscience, Inc.(NasdaqCM: DARE) added to Russell Microcap Index - marketscreener.com
Daré Bioscience, Inc.(NasdaqCM:DARE) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Dare Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5 in Virtual Investor What This Means Segment - marketscreener.com
Dare Bioscience Inc (DARE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Dare Bioscience, Inc. Actuals & Estimates (NASDAQ:DARE) - TradingView
DARE Forecast — Price Target — Prediction for 2027 - TradingView
Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor 'What This Means” Segment - The Manila Times
Daré Bioscience Highlights Revenue Opportunity as CEO - GlobeNewswire
Daré Bioscience, Inc. (DARE) Presents at BIO International Convention 2026Slideshow (NASDAQ:DARE) 2026-06-23 - Seeking Alpha
Daré Bioscience Issues New Corporate Investor Presentation - TipRanks
Form 8K Dare Bioscience Inc For: 22 June By Investing.com - Investing.com South Africa
Dare Bioscience (DARE) unveils June 22, 2026 corporate investor presentation - Stock Titan
Daré Bioscience to Present Corporate Strategy and Participate in Multiple Speaking Engagements at BIO International Convention 2026 - Quiver Quantitative
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026 - GlobeNewswire
Dare Bioscience Inc (DARE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Dare Bioscience Inc (DARE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Dare Bioscience Inc (DARE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Dare Bioscience Inc (DARE) Institutional Confidence - TradingKey
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):